Yanch J C, Zhou X L, Brownell G L
Department of Nuclear Engineering, Massachusetts Institute of Technology, Cambridge 02139.
Radiat Res. 1991 Apr;126(1):1-20.
A Monte Carlo simulation study has been carried out to investigate the suitability of neutron beams of various energies for therapeutic efficacy in boron neutron capture therapy. The dosimetric properties of unidirectional, monoenergetic neutron beams of varying diameters in two different phantoms (a right-circular cylinder and an ellipsoid) made of brain-equivalent material were examined. The source diameter was varied from 0.0 to 20.0 cm; neutron energies ranged from 0.025 eV up to 800 keV, the maximum neutron energy generated by a tandem cascade accelerator using 2.5-MeV protons in a 7Li(p,n)7Be reaction. Such a device is currently under investigation for use as a neutron source for boron neutron capture therapy. The simulation studies indicate that the maximum effective treatment depth (advantage depth) in the brain is 10.0 cm and is obtainable with a 10-keV neutron beam. A useful range of energies, defined as those neutron energies capable of effectively treating to a depth of 7 cm in brain tissue, is found to be 4.0 eV to 40.0 keV. Beam size is shown not to affect advantage depth as long as the entire phantom volume is used in determining this depth. Dose distribution in directions parallel to and perpendicular to the beam direction are shown to illustrate this phenomenon graphically as well as to illustrate the differences in advantage depth and advantage ratio and the contribution of individual dose components to tumor dose caused by the geometric differences in phantom shape.
已开展一项蒙特卡罗模拟研究,以探究不同能量的中子束在硼中子俘获治疗中对治疗效果的适用性。研究了由脑等效材料制成的两种不同体模(一个右旋圆柱体和一个椭球体)中不同直径的单向单能中子束的剂量学特性。源直径从0.0厘米变化到20.0厘米;中子能量范围从0.025电子伏特到800千电子伏特,这是使用2.5兆电子伏特质子在7Li(p,n)7Be反应中由串联加速器产生的最大中子能量。这种装置目前正在作为硼中子俘获治疗的中子源进行研究。模拟研究表明,大脑中的最大有效治疗深度(优势深度)为10.0厘米,使用10千电子伏特的中子束可获得该深度。发现有用的能量范围,即能够有效治疗脑组织7厘米深度的那些中子能量,为4.0电子伏特到40.0千电子伏特。只要在确定该深度时使用整个体模体积,束大小就不会影响优势深度。展示了平行于和垂直于束方向的剂量分布,以图形方式说明这一现象,以及说明优势深度和优势比的差异,以及由体模形状的几何差异导致的各个剂量分量对肿瘤剂量的贡献。